Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK13 | O15264 | 14/20 | 0.67 |
| ▸ | GCGR | P47871 | 14/20 | 0.67 |
| ▸ | MAPK12 | P53778 | 14/20 | 0.67 |
| ▸ | MAPK11 | Q15759 | 14/20 | 0.67 |
| ▸ | MAPK14 | Q16539 | 14/20 | 0.67 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.67 |
| ▸ | MAP4K4 | O95819 | 3/20 | 0.67 |
| ▸ | FRK | P42685 | 3/20 | 0.67 |
| ▸ | MAPK9 | P45984 | 3/20 | 0.67 |
| ▸ | CSNK1A1 | P48729 | 3/20 | 0.67 |
| ▸ | CSNK1D | P48730 | 3/20 | 0.67 |
| ▸ | GSK3B | P49841 | 3/20 | 0.67 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.67 |
| ▸ | PTK6 | Q13882 | 2/20 | 0.67 |
| ▸ | PRKD2 | Q9BZL6 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18960545 | 0.88 | ALDH1A1 (0.67) | MAPK13GCGRMAPK12MAPK11MAPK14 | |
| SCHEMBL19868925 | 0.82 | MAPK11 (1.00) | MAPK13GCGRMAPK12MAPK11MAPK14 | |
| SCHEMBL15075603 | 0.82 | MAPK11 (1.00) | MAPK13GCGRMAPK12MAPK11MAPK14 | |
| SCHEMBL2650097 | 0.80 | MAPK14 (0.78) | MAPK13GCGRMAPK12MAPK11MAPK14 | |
| SCHEMBL2650680 | 0.78 | ALOX5 (0.77) | MAPK13GCGRMAPK12MAPK11MAPK14 | |
| SCHEMBL2648011 | 0.78 | MAPK14 (0.76) | MAPK13GCGRMAPK12MAPK11MAPK14 | |
| SCHEMBL6465326 | 0.78 | MAPK13 (0.74) | MAPK13GCGRMAPK12MAPK11MAPK14 | |
| SCHEMBL2648428 | 0.78 | MAPK13 (0.74) | MAPK13GCGRMAPK12MAPK11MAPK14 | |
| SCHEMBL4552316 | 0.77 | MAPK14 (1.00) | MAPK13GCGRMAPK12MAPK11MAPK14 | |
| SCHEMBL2650702 | 0.77 | MAPK11 (1.00) | MAPK13GCGRMAPK12MAPK11MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10865384-B2 | 2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-12-15 | — | — | US | disclosed |
| US-20170166867-A1 | 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-06-15 | — | — | US | disclosed |
| US-20170166867-A1 | 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-06-15 | — | — | US | disclosed |
| WO-2015119579-A1 | 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10865384-B2 | 2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis | CSNK1A1, CSNK1G1, CSNK2A1 | MAPK13 234/4885GCGR 3638/4885MAPK12 366/4885 |
| US-20170166867-A1 | 2,4,5-TRI-SUBSTITUTED AZOLE-BASED CASEIN KINASE 1 INHIBITORS AS INDUCERS FOR CARDIOMYOGENESIS | CSNK1A1, CSNK1G1, CSNK2A1 | MAPK13 234/4885GCGR 3638/4885MAPK12 366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.